Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Gamida Cell Ltd. | 655,896 | reported | 31 Jan 2024 | tx 3+654,759 |
| Clovis Oncology, Inc. | 83,212 | reported | 12 Jul 2021 | tx 1+83,212 |
| Tempest Therapeutics, Inc. | 1,230 | reported | 27 Jan 2026 | tx 5+35,565 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Jan 2026 | GRANT_AWARD | Tempest Therapeutics, Inc. | 1,230 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Tempest Therapeutics, Inc. | 16,000 | 0.00 USD | deriv |
| 31 Jan 2024 | GRANT_AWARD | Gamida Cell Ltd. | 480,319 | 0.00 USD | |
| 15 Jun 2023 | GRANT_AWARD | Tempest Therapeutics, Inc. | 8,200 | 0.00 USD | deriv |
| 08 Feb 2023 | GRANT_AWARD | Gamida Cell Ltd. | 58,100 | 0.00 USD | |
| 08 Feb 2023 | GRANT_AWARD | Gamida Cell Ltd. | 116,340 | 0.00 USD | deriv |
| 17 Jun 2022 | GRANT_AWARD | Tempest Therapeutics, Inc. | 3,500 | 0.00 USD | deriv |
| 06 Aug 2021 | GRANT_AWARD | Tempest Therapeutics, Inc. | 6,635 | 0.00 USD | deriv |
| 12 Jul 2021 | GRANT_AWARD | Clovis Oncology, Inc. | 83,212 | 0.00 USD | deriv |